Valuation Acepodia, Inc.

Stocks

End-of-day quote Taipei Exchange 30/10/2026			5-day change	1st Jan Change
12.80 ^TWD	-4.12%		-4.12%	-16.61%

09-04	Acepodia Receives FDA Clearance for Ind Application for ACE723, A Novel Dual-Payload Antibody-Drug Conjugate	CI
08-13	Acepodia, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025
Market Cap ¹	19,362	9,977	8,936
Change	-	-48.47%	-10.43%
Enterprise Value (EV) ¹	13,342	4,157	5,395
Change	-	-68.84%	29.77%
P/E	-23.7x	-20x	-11.8x
PBR	3.01x	1.58x	1.65x
PEG	0.2x	0.5x	-0.2x
Capitalization / Revenue	1,166,891,707x	23,364,805,084x	48,303,239,524x
EV / Revenue	-	-	-
EV / EBITDA	-31.5x	-5.75x	-5.97x
EV / EBIT	-30.6x	-5.49x	-5.57x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-1.441	-0.871	-1.301
Distribution rate	-	-	-
Net sales	16.59	0.427	0.185
EBITDA ¹	-423.7	-722.8	-903.4
EBIT ¹	-436	-757.9	-969.2
Net income ¹	-817.3	-496.7	-754.4
Net Debt ¹	-6,020	-5,820	-3,541
Reference price ²	34.15	17.45	15.35
Nbr of stocks (in thousands)	566,976	571,735	582,156
Announcement Date	25/03/24	19/03/25	25/03/26

¹TWD in Million²TWD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ACEPODIA, INC.	-	-	-	-	229M
WUXI APPTEC CO., LTD.	16.87x	6.34x	12.15x	1.77%	63.77B
ARGENX SE	30.14x	8.25x	27.02x	0.04%	56.37B
LONZA GROUP AG	37.48x	6.65x	19.85x	0.86%	54.62B
IQVIA HOLDINGS INC.	34.93x	3.32x	14.34x	-.--%	44.06B
BEONE MEDICINES AG	48.85x	5.63x	30.81x	-.--%	42.11B
REVOLUTION MEDICINES, INC.	-19.86x	192.36x	-21.16x	-.--%	41B
GENMAB A/S	47.33x	8.41x	28.18x	-.--%	34.92B
CELLTRION, INC.	32x	8.13x	21.15x	0.41%	32.82B
INSMED INCORPORATED	-64.56x	13.05x	-73.23x	-.--%	24.7B
Average	18.13x	28.02x	6.57x	0.34%	39.46B
Weighted average by Cap.	22.09x	26.34x	10.94x	0.45%